Dry Powder Inhaler Industry Anticipated to Hit US$ 29.6 Billion by 2031, With 4.6% of CAGR | FMI

Climbing to New Heights: The Global Dry Powder Inhaler Industry Anticipates Impressive 4.6% CAGR Growth from 2021 to 2031, Envisioning a Market Valued at Approximately US$ 18.9 Billion in 2021. Future Market Insights’ Projections Highlight the Dominance of Manually Operated Inhaler Devices, Commanding a Significant 70.9% Share of the Global Dry Powder Inhaler Market in 2021.

Challenges Regarding Varying Characteristics of Dry Powder Inhalers to Pave Opportunities for Medical Device Manufacturers

Regulatory pressures and changes in drug delivery market have driven innovation of the dry powder inhaler forward.

Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-5150

According to the World Health Organization (WHO), nearly 300 Mn people worldwide are affected by asthma, and approximately 240 Mn from the chronic obstructive pulmonary disease (COPD).

Over half of these patients combined prefer use of dry powder inhalers for treatment of their disease.

These devices have depicted great potential in effective and reliable drug delivery, with novel designs ensuring the possibility to overcome future compliance, cost, and safety challenges.

Some of the essential performance characteristics regarding dry powder inhalers are associated with dose-delivery, performances at varying airflows, and fine particle fraction content.

These characteristics may vary with respect to powder formulations, creating the need for fine tuning of the device or powder formulation or both combined for achieving optimal performance.

The requirement is particularly high in micro-dosing dry powder inhalers, which in turn is paving opportunities for medical device manufacturers in terms of innovations and advancements.

Growing adoption of unhealthy lifestyle, increasing geriatric population, and growing air pollution levels fuelling prevalence of various respiratory disorders are key factors driving expansion of the globaldry powder inhaler market.

In addition, favorable government initiatives being taken across the globe for improving the healthcare infrastructure will further influence the market growth in the near future.

However, the fact that dry powder inhalers are not moisture-resistant remains a major challenge for manufacturers, as the medicine loses its properties when it comes in contact with the moisture.

Availability of effective alternatives such as nebulizers and electric pumps are expected to restrain adoption of dry powder inhalers.

Lack of awareness regarding these devices in low-income & underdeveloped countries may further hinder the market growth to a certain extent.

Key Research Findings from FMI’s Report on Dry Powder Inhaler Market

• North America will continue to be the most lucrative region for growth of the dry powder inhaler market. Dry powder inhaler sales in the region will register the fastest expansion through 2031. Asia-Pacific excluding Japan (APEJ) is expected to be the second largest market for dry powder inhaler.
• Hospital pharmacies will continue to be the leading distribution channel for dry powder inhalers, with sales pegged to surpass 150,000 Mn units by 2031-end.
• Dry powder inhalers will continue to observe the largest application in the treatment of asthma, followed by chronic obstructive pulmonary disease. In addition, sales of dry powder inhalers for application in the treatment of asthma and pulmonary arterial hypertension are slated to exhibit a parallel growth through 2031.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/5150

Leading companies in the global dry powder inhaler market are focusing on the development of new generation products.

These market players are making huge investments in R&D activities associated with novel device architectures, particle engineering, and powder formulations.

Key Market Segments Covered In Dry Powder Inhalers Industry Research

By Product :

• Single Dose Dry Powder Inhalers
• Multi Dose Dry Powder Inhalers

By Indication :

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Pulmonary Arterial Hypertension
• Diabetes
• Cystic Fibrosis

By Function :

• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices

By End User :

• Institutional Sales
  • Hospital Pharmacies
  • Cancer Research
  • Office based Speciality Clinics
• Retail Sales
  • Retail Pharmacies
  • Drug Stores
• Mail Order Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube